← Leaderboards
Hua Wu
Sab Biotherapeutics, Inc.
$1,559,434
Attributed
$3,118,868
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $2M · FY2019–20$2M$1.5M$1M$500K$0
'19
'20
Funding mix
By agency
NIH$3,118,868 · 2
By mechanism
R44$1,617,711 · 1
R42$1,501,157 · 1
Top collaborators
- Alexei Yurievitch Savinov3 shared
- Irina A. Polejaeva2 shared
Most similar at Sab Biotherapeutics, Inc.
Same institution · by research overlap
- Jinan Jiao$378,040
- Christoph Bausch$335,238
Others in their field
Other Emerging Leaders on “Immunization”
- Bambra Strokes · Ppd Development Lp$526,656,217
- Ethan Dmitrovsky · Leidos Biomedical Research, Inc.$181,310,675
- Kevin Urdahl · Seattle Children'S Hospital$84,741,409
- Ted Ross · University Of Georgia$74,507,826
- Yunda Huang · Fred Hutchinson Cancer Center$73,602,469
- Tony Moody · Duke University$66,767,417
Research focus
ImmunizationPreclinical EvaluationCollectionHyperimmunizationPlasmaPolyclonal Human AntibodyAdjuvantCellsEfficacy StudyEnsureImmunoglobulin GImmunoglobulinsAnaphylaxisCattleAutoimmunityBacteriaBaseAnimalsAntibodiesBiological Response Modifier TherapyAntibody FormationEmbryoAntigensPreparation
Grant awards (5)
Production and Characterization of Human Immunoglobulin Producing Goats for Diagnostic Reagents and Therapeutics$743,067
R42 · FY2020 · AI · contact PI
Advancing a Candidate Human Polyclonal Anti-Thymocyte Globulin Product Produced in Transchromosomal Bovine for Transplant Induction/Acute Rejection and T1D Therapy$418,106
R44 · FY2020 · AI · contact PI
Advancing a Candidate Human Polyclonal Anti-Thymocyte Globulin Product Produced in Transchromosomal Bovine for Transplant Induction/Acute Rejection and T1D Therapy$1,000,000
R44 · FY2019 · AI · contact PI
Production and Characterization of Human Immunoglobulin Producing Goats for Diagnostic Reagents and Therapeutics$758,090
R42 · FY2019 · AI · contact PI
Advancing a Candidate Human Polyclonal Anti-Thymocyte Globulin Product Produced in Transchromosomal Bovine for Transplant Induction/Acute Rejection and T1D Therapy$199,605
R44 · FY2019 · AI · contact PI